Target intelligence / Profile preview

CRISPR–Cas target sequence (null)

Target
null
Molecular classification
Other
01

Overview

The **CRISPR–Cas target sequence** is a short, user-selected segment of DNA (or, in specific Cas systems, RNA) in a cell’s genome that is recognized through base pairing with the guide RNA of a CRISPR–Cas system and subsequently cleaved or edited by the associated Cas protein[2][6][7][8]. The target sequence must be adjacent to a specific short motif (the PAM sequence for most Cas systems), and its precise genetic context is selected according to experimental or therapeutic objectives. The sequence itself is not a biological entity, but rather a designation for any site that is intentionally targeted for genome engineering. Safety and efficacy of targeting depend heavily on the specificity of guide RNA design and the molecular context of cleavage.

Other names
target DNA sequenceprotospacer sequencetarget locustarget RNA sequence
02

Mechanism of action

null

03

Biological functions

Other
04

Disease associations

Other
05

Safety considerations

Off-target effects (CRISPR systems can sometimes cleave sequences similar to the intended target, leading to unintended mutations)[1][2][6].Double-strand breaks (may introduce genomic instability or activate DNA damage responses)[1][6].Imprecise repairs (non-homologous end joining can introduce indels at the cleavage site)[1][6].

Beyond the preview

Go deeper on CRISPR–Cas target sequence (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CRISPR–Cas target sequence (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call